International Congress Barcelona 2013

---

---

ERS/JAMA Lunchtime session "Advances in IPF, bronchiectasis and sarcoidosis"

Symposium
Chairs: G. O'Connor (Boston, United States of America), G. Brusselle (Ghent, Belgium)
Aims: The aims of this lunchtime are as follow:
- the audience will be informed about new research findings on the role of genetic variants as risk factors for IPF and as determinants of IPF prognosis;
- the audience will be informed about the benefits of long-term macrolide therapy in reducing exacerbations of non-CF bronchiectasis but also about the potential risks of the emergence of bacterial resistance;
- and the audience will be informed about the optimal approach to the diagnostic evaluation of patients suspected to have sarcoidosis.

Genetics of IPF D. Schwartz (Aurora, United States of America)
Long-term macrolide therapy for non-CF bronchiectasis J.S. Elborn (Belfast, United Kingdom)
Advances in the diagnostic approach to sarcoidosis J. Annema (Amsterdam, Netherlands)